Authentidate Holding Corp. announced the launch of an innovative new Women’s Health diagnostic test, MDx Advantage, which utilizes Molecular Microbiology to improve on the legacy testing methods. Traditionally, vaginal infections are diagnosed using a combination of gynecological examinations including a vaginal pH test, a microscopic evaluation (gram-stain and/or wet mount), and an amine odor test. However, such procedures have approximately a 30% chance of failure and cannot detect common, mixed infections. Aeon’s innovative approach enables accurate and rapid detection and diagnosis of such infections, including sexually transmitted diseases such as chlamydia and gonorrhea, candidiasis, bacterial vaginosis (BV), and others. Aeon’s Molecular Microbiology approach facilitates broad coverage of vaginal flora by targeting thirty-four (34) different microbial organisms including bacteria, fungi, viruses, and protozoa. This testing provides significant advantages over the use of the traditional diagnostics including improved accuracy (testing will distinguish microbes down to the species level), faster turnaround time, and an easy-to-read report. MDx Advantage™ is an excellent new option for Aeon’s physician clients with patients presenting with vaginal infection symptoms and requiring a quick and accurate diagnosis.